Resultados da busca - Pinter A

Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review por Pinter A, Bonnekoh B, Hadshiew IM, Zimmer S

Obter o texto integral

Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature por Pinter A, Thormann H, Angeletti F, Jalili A

Obter o texto integral

Conformational heterogeneity in V1/V2 domain affects the immunological properties of this region por Pinter A, Wu AZ, Neubert T, Burkhart MD, Honnen WJ

Neuropsychiatric symptoms in untreated Parkinson’s disease por Szatmari S, Illigens BM, Siepmann T, Pinter A, Takats A, Bereczki D

Obter o texto integral

Cardiac dysautonomia in depression – heart rate variability biofeedback as a potential add-on therapy por Pinter A, Szatmari S Jr, Horvath T, Penzlin AI, Barlinn K, Siepmann M, Siepmann T

Obter o texto integral

Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals por Krachmarov C, Revesz K, Prattipati R, Reichman C, Lai Z, Honnen W, Li B, Derdeyn C, Pinter A

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. por Girard, M, Kieny, M P, Pinter, A, Barre-Sinoussi, F, Nara, P, Kolbe, H, Kusumi, K, Chaput, A, Reinhart, T, Muchmore, E

Obter o texto integral
Obter o texto integral
Obter o texto integral

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope por Wang S, Seaman MS, Krachmarov C, Pinter A, Totrov M, Gorny MK, Jiang X, Cohen S, Hioe C, Cardozo T, Kong X, Zolla-Pazner S, Lu S

Detection of antibodies to the α4β7 integrin binding site on HIV-1 gp120 V2 loop using a novel cell adhesion assay por Rao M, Karasavvas N, Pinter A, Liao H, Bonsignori M, Mathieson B, Zolla-Pazner S, Haynes BF, Michael NL, Kim JH, Alving CR, Peachman KK

P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape por Gnanakaran S, Shaw GM, Pinter A, Blackwell JL, Allen SA, Mulenga J, Murphy MK, Haaland RE, Li B, Rong R, Hunter E, Robinson JE, Derdeyn CA

Construction of SHIVs expressing quaternary neutralization epitopes in Env and mimicking the neutralization phenotype of typical HIV-1 isolates por Theis JF, de Parseval A, Honnen WJ, Phogat A, Ganapathi UC, Lai Z, Peng L, Reichman C, Moore PL, Morris L, Li Y, Hu S, Pinter A

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2 por Liao L, Bonsignori M, Hwang K, Moody AM, Park R, Crawford S, Chen H, Jeffries TL, Cooper M, Lu X, De R, Karasavvas N, Rerks-Ngarm S, Nitayaphan S, Kaewkungwal J, Tovanabutra S, Pitisuttithum P, Tartaglia J, Sinangil F, Kim J, Michael NL, Tomaras GD, Yang Z, Dai K, Pancera M, Nabel GJ, Mascola JR, Kwong PD, Pinter A, Zolla-Pazner S, Alam MS, Haynes BF